Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion type Assertion NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_head.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion description "[In large studies with extended follow-up periods, tumor size, tumor grade, cathepsin-D, Ki-67, S-phase fraction, mitotic index, and vascular invasion showed a significant association with survival outcome measures in patients with early-stage node-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_provenance.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion evidence source_evidence_literature NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_provenance.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion SIO_000772 11753038 NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_provenance.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion wasDerivedFrom befree-20140225 NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_provenance.
- NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_assertion wasGeneratedBy ECO_0000203 NP299132.RABHF1dDXmSsw9R5EufAeF2pT9-o4KzwHWZLofc3tgp38130_provenance.